Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 2/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.34 |
| ▸ | CSNK1D | P48730 | 9/20 | 0.34 |
| ▸ | CSNK1E | P49674 | 9/20 | 0.34 |
| ▸ | F12 | P00748 | 1/20 | 0.33 |
| ▸ | STS | P08842 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16728645 | 0.87 | NR1H2 (0.36) | ADORA1NR1H2CSNK1DCSNK1EF12 | |
| SCHEMBL16711291 | 0.85 | CSNK1E (0.43) | CSNK1DCSNK1E | |
| SCHEMBL16699166 | 0.83 | ADORA1 (0.44) | ADORA1NR1H2CSNK1DCSNK1EESR2 | |
| SCHEMBL16699234 | 0.79 | ADORA1 (0.48) | ADORA1NR1H2CSNK1DF12ESR2 | |
| SCHEMBL16728558 | 0.78 | CSNK1E (0.44) | CSNK1DCSNK1E | |
| SCHEMBL16728629 | 0.77 | CSNK1E (0.44) | CSNK1DCSNK1E | |
| SCHEMBL16728559 | 0.77 | CSNK1E (0.58) | CSNK1DCSNK1E | |
| SCHEMBL26645063 | 0.72 | NR1H2 (0.38) | ADORA1NR1H2F12STSESR2 | |
| SCHEMBL22716585 | 0.71 | NR1H2 (0.39) | NR1H2F12STSESR2ALDH1A1 | |
| SCHEMBL22718580 | 0.71 | NR1H2 (0.37) | ADORA1NR1H2F12STSESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015073767-A1 | SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-05-21 | — | — | WO | disclosed |